药物诱导性皮肤肌炎:FDA不良事件报告系统的药监测研究
Jianing Bi1, Hanzhang Xie2, Yixuan Yang1
1Department of Dermatology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Frontiers in pharmacology
|October 17, 2025
概括
这项研究使用FDA数据确定了353种可能导致皮肤肌炎 (DM) 的药物. 心血管药物,免疫疗法和化疗剂最常涉及,有助于更安全的处方实践.
科学领域:
- 药物监督 药物监督 药物监督
- 自免疫性疾病 自免疫性疾病
- 药品安全 药品安全
背景情况:
- 皮肤肌肉炎 (DM) 是一种可能由药物引发的自身免疫性疾病.
- 以前的研究集中在特定的药物上,缺乏对药物诱导的DM的广泛概述.
- 美国食品和药物管理局的不良事件报告系统 (FAERS) 为全面的药物-DM相关性研究提供了宝贵的资源.
研究的目的:
- 使用FAERS数据进行药物诱导性皮肤肌炎的综合分析.
- 确定特定的药物类别和与DM相关的药物.
- 通过更好地预测药物-DM相关性来提高患者的安全性.
主要方法:
- 利用了2004年1月至2024年6月的FAERS数据.
- 使用MedDRA编码和分类的不良事件.
- 进行多次不成比例分析 (ROR,PRR,BCPNN,MGPS) 来检测药物事件关联.
主要成果:
- 从1767个FAERS报告中确定了353种疑似诱导DM的药物.
- 发现了24种信号阳性药物.
- 心血管药物 (特别是他类药物),免疫治疗剂 (免疫检查点抑制剂) 和化疗剂 (抗代谢物) 最常见.
结论:
- 这项研究提供了一种基于证据的新方法,用于合理的药物处方,以预防药物诱导的DM.
- 先进的算法提高了预测药物-DM相关性的精度,提高了患者的安全性.
- 提供临床指导,以避免与DM相关的药物在危险患者.
更多相关视频
相关概念视频
Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
Drug Regulation
2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K
Therapeutic Drug Monitoring: Affecting Factors
200
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
200
FDA Approved Drugs: Changes to Approved Drugs
240
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
240
Therapeutic Drug Monitoring: Overview and Classification
306
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
306
Therapeutic Drug Monitoring: Drug Analysis Methods
176
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
176


